More Subjects Achieved Composite Reductions of ≥1% HbA1C, ≥5% Body Weight and ≥5 mmHg Systolic Blood Pressure with Semaglutide vs. Comparators (SUSTAIN 1–5, 7)Lawrence A. Leiter,Kathleen Dungan,Vanita R. Aroda,Filip Krag Knop, Nanna Leonora Lausvig,Søren Lindberg,Juris MeierCanadian Journal of Diabetes（2018）引用 0|浏览48暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
